Literature DB >> 15170764

Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database.

M Ståhl1, M Lindquist, I R Edwards, E G Brown.   

Abstract

PURPOSE: An important role for the WHO Programme for International Drug Monitoring is to identify signals of international drug safety problems as early as possible. The signal detection strategy, operated at the Uppsala Monitoring Centre (UMC), gave too many drug-adverse drug reaction (ADR) combinations for individual review. Therefore additional selection strategies were needed to improve the likely signal-to-noise ratio and for the UMC to complement the efforts of national centres in an efficient way.
METHODS: The combinations database of the first quarter of 2001 was analysed using algorithms representing different strategies for finding relevant signals using triage logic.
RESULTS: The strategies that together gave a manageable number of combinations, i.e. around 600, for further consideration in a single quarter were the algorithms for 'Rapid reporting increase', 'Serious reaction and new drug' and 'Special interests'. These filters began to be used routinely on the combinations database in late 2001.
CONCLUSIONS: While stressing that human review is essential, triage strategies are useful when attempting analysis of large amounts of data. By definition, the use of triage strategies may exclude some potential signals from consideration, although the intention is to improve the chances of detection by focussing on areas of greatest importance. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15170764     DOI: 10.1002/pds.894

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  20 in total

1.  A decade of data mining and still counting.

Authors:  Manfred Hauben; G Niklas Norén
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

Review 2.  Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

Authors:  David W J Clark; Johanna Strandell
Journal:  Eur J Clin Pharmacol       Date:  2006-04-22       Impact factor: 2.953

3.  Impact analysis of signals detected from spontaneous adverse drug reaction reporting data.

Authors:  Patrick Waller; Emma Heeley; Jane Moseley
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Perspectives on the use of data mining in pharmaco-vigilance.

Authors:  June Almenoff; Joseph M Tonning; A Lawrence Gould; Ana Szarfman; Manfred Hauben; Rita Ouellet-Hellstrom; Robert Ball; Ken Hornbuckle; Louisa Walsh; Chuen Yee; Susan T Sacks; Nancy Yuen; Vaishali Patadia; Michael Blum; Mike Johnston; Charles Gerrits; Harry Seifert; Karol Lacroix
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?

Authors:  Ana F Macedo; Francisco B Marques; Carlos F Ribeiro
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  What counts in data mining?

Authors:  Manfred Hauben; Vaishali K Patadia; David Goldsmith
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.

Authors:  Yasuyuki Matsushita; Yasufumi Kuroda; Shinpei Niwa; Satoshi Sonehara; Chikuma Hamada; Isao Yoshimura
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

8.  A model for decision support in signal triage.

Authors:  Bennett Levitan; Chuen L Yee; Leo Russo; Richard Bayney; Adrian P Thomas; Stephen L Klincewicz
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

9.  Impact of stratification on adverse drug reaction surveillance.

Authors:  Johan Hopstadius; G Niklas Norén; Andrew Bate; I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Detecting unexpected adverse drug reactions in children.

Authors:  Kristina Star
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.